Speaker: Michelle Boyle - QIMR Berghofer Medical Research Institute - Host Alex Maier & IRTG
A key mediator of protective immunity to malaria is antibodies that block merozoite invasion of the RBC.
Speaker: Associate Professor Ashley Buckle - Monash University - Head, Protein Engineering and Design Lab - Host - Denisse Leyton
α-1 antitrypsin (AAT) is used as augmentation therapy in patients with AAT deficiency (AATD)-related emphysema, and is a promising therapeutic for treatment of a wide range of i
Speaker: Dr Teresa Carvalho - Head of the Molecular Parasitology Lab La Trobe University - Host Alex Maier
Malaria causes a significant health burden worldwide. An efficient vaccine has yet to be developed but a handful of treatment options exist.
Speaker: Dieter Schmoll, Sanofi - Host Stefan Broer
Chronic oxidative stress has been postulated to drive insulin resistance and diabetic complications.